{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:58:40Z","timestamp":1791986320787,"version":"4.4.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202206240086"],"award-info":[{"award-number":["202206240086"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.phrs.2024.107302","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T05:26:25Z","timestamp":1720848385000},"page":"107302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review"],"prefix":"10.1016","volume":"206","author":[{"given":"Zhouting","family":"Tuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengxiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruicheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilinaer","family":"Wusiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koo Han","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzoamaka Adaobi","family":"Okoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Heavey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuran","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107302_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca Cancer J. Clin."},{"key":"10.1016\/j.phrs.2024.107302_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11547-022-01513-5","article-title":"A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study","volume":"127","author":"Bicchetti","year":"2022","journal-title":"Radio. Med"},{"key":"10.1016\/j.phrs.2024.107302_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2024.107302_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"Ca Cancer J. Clin."},{"key":"10.1016\/j.phrs.2024.107302_bib6","first-page":"163","article-title":"Role of natural products in tumor therapy from basic research and clinical perspectives","volume":"3","author":"Wang","year":"2024","journal-title":"Acta Mater. Med."},{"key":"10.1016\/j.phrs.2024.107302_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106654","article-title":"Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin \u03b15\/\u03b21-FAK\/Src axis: a novel strategy for drug application","volume":"188","author":"Wu","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40824-022-00328-9","article-title":"Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate","volume":"26","author":"Xiang","year":"2022","journal-title":"Biomater. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.phrs.2024.107302_bib10","first-page":"20220086","article-title":"Mesoporous silica\/organosilica nanoparticles for cancer immunotherapy","volume":"3","author":"Theivendran","year":"2023","journal-title":"Explor. (Beijing)"},{"key":"10.1016\/j.phrs.2024.107302_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.32604\/or.2023.042383","article-title":"Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy","volume":"32","author":"Chen","year":"2023","journal-title":"Oncol. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.annonc.2022.11.012","article-title":"Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up","volume":"34","author":"Balar","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phrs.2024.107302_bib13","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular characterization of urothelial bladder carcinoma, Nature. 507 (2014) 315-322, https:\/\/doi.org10.1038\/nature12965.","DOI":"10.1038\/nature12965"},{"key":"10.1016\/j.phrs.2024.107302_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107302_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41568-021-00336-2","article-title":"Genetic and non-genetic clonal diversity in cancer evolution","volume":"21","author":"Black","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2024.107302_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.34133\/research.0036","article-title":"Comprehensive metabolic profiling and genome-wide analysis reveal therapeutic modalities for hepatocellular carcinoma","volume":"6","author":"Qi","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.phrs.2024.107302_bib17","series-title":"On the origin of species by means of natural selection: Or the preservation of the favoured races in the struggle for life","author":"Charles","year":"1860"},{"key":"10.1016\/j.phrs.2024.107302_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107302_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","article-title":"Identification of the tumour transition states occurring during EMT","volume":"556","author":"Pastushenko","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107302_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1158\/1541-7786.MCR-19-1158","article-title":"Convergent evolution, evolving evolvability, and the origins of lethal cancer","volume":"18","author":"Pienta","year":"2020","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41576-019-0114-6","article-title":"Resolving genetic heterogeneity in cancer","volume":"20","author":"Turajlic","year":"2019","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.phrs.2024.107302_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2017.01.003","article-title":"Tumor evolution: linear, branching, neutral or punctuated?","volume":"1867","author":"Davis","year":"2017","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.phrs.2024.107302_bib23","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1200\/EDBK_158930","article-title":"Tumor evolutionary principles: how intratumor heterogeneity influences cancer treatment and outcome","volume":"35","author":"Venkatesan","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.phrs.2024.107302_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng.3214","article-title":"A big bang model of human colorectal tumor growth","volume":"47","author":"Sottoriva","year":"2015","journal-title":"Nat. Genet"},{"key":"10.1016\/j.phrs.2024.107302_bib25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","article-title":"Punctuated evolution of prostate cancer genomes","volume":"153","author":"Baca","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41588-018-0105-0","article-title":"Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma","volume":"50","author":"DeCarvalho","year":"2018","journal-title":"Nat. Genet"},{"key":"10.1016\/j.phrs.2024.107302_bib28","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103148","article-title":"Nomenclature for cellular plasticity: are the terms as plastic as the cells themselves?","volume":"38","author":"Mills","year":"2019","journal-title":"Embo J."},{"key":"10.1016\/j.phrs.2024.107302_bib29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tig.2018.05.007","article-title":"Harnessing tumor evolution to circumvent resistance","volume":"34","author":"Pogrebniak","year":"2018","journal-title":"Trends Genet"},{"key":"10.1016\/j.phrs.2024.107302_bib30","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.14336\/AD.2022.0407","article-title":"Tumor immune microenvironment and immunotherapy in non-small cell lung cancer: update and new challenges","volume":"13","author":"Xing","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.phrs.2024.107302_bib31","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41416-019-0721-1","article-title":"Cancer as a disease of old age: changing mutational and microenvironmental landscapes","volume":"122","author":"Laconi","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2024.107302_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.urolonc.2018.11.015","article-title":"Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy","volume":"40","author":"Da","year":"2022","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.phrs.2024.107302_bib33","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1158\/0008-5472.CAN-16-0436","article-title":"Paired exome analysis reveals clonal evolution and potential therapeutic targets in urothelial carcinoma","volume":"76","author":"Lamy","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41585-020-0304-1","article-title":"Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes","volume":"17","author":"Meeks","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eururo.2018.09.003","article-title":"Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants","volume":"75","author":"Warrick","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106475","article-title":"Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions","volume":"185","author":"Hashemi","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib37","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.phrs.2024.107302_bib38","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/ng.3692","article-title":"Clonal evolution of chemotherapy-resistant urothelial carcinoma","volume":"48","author":"Faltas","year":"2016","journal-title":"Nat. Genet"},{"key":"10.1016\/j.phrs.2024.107302_bib39","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat. Genet"},{"key":"10.1016\/j.phrs.2024.107302_bib40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/embor.2012.61","article-title":"Cancer chromosomal instability: therapeutic and diagnostic challenges","volume":"13","author":"McGranahan","year":"2012","journal-title":"Embo Rep."},{"key":"10.1016\/j.phrs.2024.107302_bib41","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/s41366-021-00879-2","article-title":"Obesity, oxidative DNA damage and vitamin D as predictors of genomic instability in children and adolescents","volume":"45","author":"Usman","year":"2021","journal-title":"Int J. Obes. (Lond. )"},{"key":"10.1016\/j.phrs.2024.107302_bib42","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41591-020-1033-y","article-title":"Genomic copy number predicts esophageal cancer years before transformation","volume":"26","author":"Killcoyne","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2024.107302_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"de Bruin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107302_bib44","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature09460","article-title":"The patterns and dynamics of genomic instability in metastatic pancreatic cancer","volume":"467","author":"Campbell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107302_bib45","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib46","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1158\/0008-5472.CAN-21-0653","article-title":"The evolving genomic landscape of esophageal squamous cell carcinoma under chemoradiotherapy","volume":"81","author":"Hirata","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib47","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1158\/2159-8290.CD-18-0264","article-title":"The genetic landscape and clonal evolution of breast cancer resistance to palbociclib plus fulvestrant in the PALOMA-3 Trial","volume":"8","author":"O'Leary","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phrs.2024.107302_bib48","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41467-017-02320-7","article-title":"Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107302_bib49","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107302_bib50","first-page":"1033","article-title":"Comprehensive molecular characterization of muscle-invasive bladder","volume":"174","author":"Robertson","year":"2018","journal-title":"Cancer, Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib51","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccell.2017.08.005","article-title":"Genomic subtypes of non-invasive bladder cancer with distinct metabolic profile and female gender bias in KDM6A mutation frequency","volume":"32","author":"Hurst","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib52","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/0008-5472.CAN-22-2912","article-title":"The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer","volume":"83","author":"Liu","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib53","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.celrep.2014.04.038","article-title":"Mutational context and diverse clonal development in early and late bladder cancer","volume":"7","author":"Nordentoft","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2024.107302_bib54","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1158\/2159-8290.CD-20-0725","article-title":"Induction of APOBEC3 Exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution","volume":"11","author":"Venkatesan","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phrs.2024.107302_bib55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ng.2701","article-title":"Evidence for APOBEC3B mutagenesis in multiple human cancers","volume":"45","author":"Burns","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1016\/j.phrs.2024.107302_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601737","article-title":"The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer","volume":"2","author":"Law","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2024.107302_bib57","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199803263381305","article-title":"CDKN2A mutations in multiple primary melanomas","volume":"338","author":"Monzon","year":"1998","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2024.107302_bib58","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCRESAHA.118.314063","article-title":"Tumor Suppressors RB1 and CDKN2a Cooperatively Regulate Cell-Cycle Progression and Differentiation During Cardiomyocyte Development and Repair","volume":"124","author":"Hatzistergos","year":"2019","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib59","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1073\/pnas.1310522110","article-title":"TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism","volume":"110","author":"Rachakonda","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107302_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102423118","article-title":"TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer","volume":"118","author":"Agarwal","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107302_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/onc.2016.172","article-title":"Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response","volume":"36","author":"Nickerson","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2024.107302_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/1541-7786.MCR-17-0260","article-title":"Functional impact of chromatin remodeling gene mutations and predictive signature for therapeutic response in bladder cancer","volume":"16","author":"Duex","year":"2018","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1101\/gad.350740.123","article-title":"DNA damage remodels the MITF interactome to increase melanoma genomic instability","volume":"38","author":"Binet","year":"2024","journal-title":"Genes Dev."},{"key":"10.1016\/j.phrs.2024.107302_bib64","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1158\/0008-5472.CAN-20-0977","article-title":"Genomic predictors of good outcome, recurrence, or progression in high-grade T1 non-muscle-invasive bladder cancer","volume":"80","author":"Bellmunt","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib65","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/onc.2009.280","article-title":"Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner","volume":"28","author":"di Martino","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2024.107302_bib66","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1038\/sj.onc.1208705","article-title":"FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma","volume":"24","author":"Jebar","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2024.107302_bib67","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1158\/0008-5472.CAN-22-1444","article-title":"KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer","volume":"83","author":"Qiu","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib68","doi-asserted-by":"crossref","first-page":"25732","DOI":"10.1073\/pnas.2008017117","article-title":"Loss of UTX\/KDM6A and the activation of FGFR3 converge to regulate differentiation gene-expression programs in bladder cancer","volume":"117","author":"Barrows","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107302_bib69","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1126\/science.aba8347","article-title":"Extensive heterogeneity in somatic mutation and selection in the human bladder","volume":"370","author":"Lawson","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107302_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1008","article-title":"Non-invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study","volume":"12","author":"Xiao","year":"2022","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.phrs.2024.107302_bib72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib73","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrurol.2017.11","article-title":"The evolving genomic landscape of urothelial carcinoma","volume":"14","author":"Glaser","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib74","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.eururo.2022.09.008","article-title":"Elevated T-cell exhaustion and urinary tumor DNA levels are associated with bacillus Calmette-Gu\u00e9rin failure in patients with non-muscle-invasive bladder cancer","volume":"82","author":"Strandgaard","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib75","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eururo.2009.04.009","volume":"56","author":"J\u00e4rvinen","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib76","article-title":"Prognostic significance of HER2 expression in patients with bacillus calmette-gu\u00e9rin-exposed non-muscle-invasive bladder cancer","author":"Tan","year":"2023","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.phrs.2024.107302_bib77","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.eururo.2003.11.018","article-title":"Pretreatment p53 nuclear overexpression as a prognostic marker in superficial bladder cancer treated with Bacillus Calmette-Gu\u00e9rin (BCG)","volume":"45","author":"Saint","year":"2004","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib78","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2010.11.031","article-title":"NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Gu\u00e9rin therapy for bladder cancer","volume":"59","author":"Chiong","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib79","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.euo.2021.11.002","article-title":"Somatic features of response and relapse in non-muscle-invasive bladder cancer treated with bacillus calmette-gu\u00e9rin immunotherapy","volume":"5","author":"Bacon","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.phrs.2024.107302_bib80","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2024.107302_bib81","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.seminoncol.2012.08.007","article-title":"New therapeutic challenges in advanced bladder cancer","volume":"39","author":"Bellmunt","year":"2012","journal-title":"Semin Oncol."},{"key":"10.1016\/j.phrs.2024.107302_bib82","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.eururo.2015.07.009","article-title":"Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer","volume":"68","author":"Plimack","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib83","article-title":"Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer","volume":"4","author":"Kim","year":"2023","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.phrs.2024.107302_bib84","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib85","doi-asserted-by":"crossref","first-page":"369","DOI":"10.14336\/AD.2023.0420","article-title":"Cancer-Associated Fibroblasts Promote Lymphatic Metastasis in Cholangiocarcinoma via the PDGF-BB\/PDGFR-\u03b2 Mediated Paracrine Signaling Network","volume":"15","author":"Yan","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.phrs.2024.107302_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106534","article-title":"Exosomal miR-625-3p secreted by cancer-associated fibroblasts in colorectal cancer promotes EMT and chemotherapeutic resistance by blocking the CELF2\/WWOX pathway","volume":"186","author":"Zhang","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib87","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","article-title":"Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib88","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-22-2213","article-title":"Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance","volume":"83","author":"Zhuang","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib89","doi-asserted-by":"crossref","first-page":"207","DOI":"10.32604\/or.2023.028163","article-title":"A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Gu\u00e9rin in patients with non-muscle invasive bladder carcinoma: a retrospective study","volume":"31","author":"Villoldo","year":"2023","journal-title":"Oncol. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib90","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41585-019-0226-y","article-title":"The multifaceted immune regulation of bladder cancer","volume":"16","author":"Schneider","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib91","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jnci\/djx243","article-title":"Prognostic power of a tumor differentiation gene signature for bladder urothelial carcinomas","volume":"110","author":"Mo","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2024.107302_bib92","doi-asserted-by":"crossref","first-page":"686","DOI":"10.21147\/j.issn.1000-9604.2023.06.12","article-title":"Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: insights from multiple omics analysis","volume":"35","author":"Tuo","year":"2023","journal-title":"Chin. J. Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib93","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12935-021-02314-y","article-title":"Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression","volume":"21","author":"Du","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.phrs.2024.107302_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1303","article-title":"PD1(hi) CD200(hi) CD4(+) exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer","volume":"13","author":"Wu","year":"2023","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.phrs.2024.107302_bib95","article-title":"CD8(+) T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy","volume":"4","author":"Huseni","year":"2023","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.phrs.2024.107302_bib96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines","volume":"85","author":"Alfred","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.phrs.2024.107302_bib98","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.devcel.2021.07.006","article-title":"Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy","volume":"56","author":"Ippolito","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib99","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"P\u00e9rez-Gonz\u00e1lez","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.phrs.2024.107302_bib100","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkac011","article-title":"Epithelial-mesenchymal transition in organ fibrosis development: current understanding and treatment strategies","volume":"10","author":"Liu","year":"2022","journal-title":"Burns Trauma"},{"key":"10.1016\/j.phrs.2024.107302_bib101","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib102","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.41651","article-title":"Neighborhood deprivation and DNA methylation and expression of cancer genes in breast tumors","volume":"6","author":"Jenkins","year":"2023","journal-title":"Jama Netw. Open"},{"key":"10.1016\/j.phrs.2024.107302_bib103","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/gutjnl-2020-321534","article-title":"Genetic architectures of proximal and distal colorectal cancer are partly distinct","volume":"70","author":"Huyghe","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2024.107302_bib104","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ng.687","article-title":"A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci","volume":"42","author":"Rothman","year":"2010","journal-title":"Nat. Genet"},{"key":"10.1016\/j.phrs.2024.107302_bib105","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1252-x","article-title":"Growth dynamics in naturally progressing chronic lymphocytic leukaemia","volume":"570","author":"Gruber","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107302_bib106","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13073-021-00931-w","article-title":"Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma","volume":"13","author":"Meiller","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.phrs.2024.107302_bib107","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature09807","article-title":"Tumour evolution inferred by single-cell sequencing","volume":"472","author":"Navin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107302_bib108","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib109","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107302_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1338","article-title":"Integrated single-cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial-fibroblast interactions in recurrent bladder cancer","volume":"13","author":"Shi","year":"2023","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.phrs.2024.107302_bib111","doi-asserted-by":"crossref","first-page":"331","DOI":"10.21147\/j.issn.1000-9604.2023.04.01","article-title":"Application of single-cell RNA sequencing in head and neck squamous cell carcinoma","volume":"35","author":"An","year":"2023","journal-title":"Chin. J. Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib112","first-page":"50","article-title":"Trends and potential of machine learning and deep learning in drug study at single-cell level","volume":"6","author":"Qi","year":"2023","journal-title":"Res. (Wash. D. C. )"},{"key":"10.1016\/j.phrs.2024.107302_bib113","article-title":"Clonal evolution and heterogeneity of osimertinib acquired resistance mechanisms in EGFR mutant lung cancer","volume":"1","author":"Roper","year":"2020","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.phrs.2024.107302_bib114","article-title":"Cancer-associated fibroblast-induced remodeling of tumor microenvironment in recurrent bladder cancer","volume":"10","author":"Liang","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.phrs.2024.107302_bib115","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1038\/s41467-023-41139-3","article-title":"Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ","volume":"14","author":"Yao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107302_bib116","article-title":"Neoadjuvant therapy for muscle-invasive bladder cancer: current clinical scenario, future perspectives, and unsolved questions","volume":"178","author":"Ruiz","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.phrs.2024.107302_bib117","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jare.2021.11.010","article-title":"Emerging strategies for the improvement of chemotherapy in bladder cancer: current knowledge and future perspectives","volume":"39","author":"Liu","year":"2022","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib118","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cmdc.201200411","article-title":"Small-molecule APOBEC3G DNA cytosine deaminase inhibitors based on a 4-amino-1,2,4-triazole-3-thiol scaffold","volume":"8","author":"Olson","year":"2013","journal-title":"Chemmedchem"},{"key":"10.1016\/j.phrs.2024.107302_bib119","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1021\/cb200440y","article-title":"First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G","volume":"7","author":"Li","year":"2012","journal-title":"Acs Chem. Biol."},{"key":"10.1016\/j.phrs.2024.107302_bib120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41467-017-00147-w","article-title":"Evasion of immunosurveillance by genomic alterations of PPAR\u03b3\/RXR\u03b1 in bladder cancer","volume":"8","author":"Korpal","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107302_bib121","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(19)30668-0","article-title":"Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial","volume":"21","author":"Petrylak","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2024.107302_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106927","article-title":"DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: a meta-analysis and systematic review","volume":"196","author":"Phan","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib123","first-page":"7","article-title":"Leveraging genomics, transcriptomics and epigenomics to understand chemoimmunotherapy resistance in chronic lymphocytic leukemia","volume":"7","author":"Ong","year":"2024","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.phrs.2024.107302_bib124","article-title":"DNA nanotechnology in tumor liquid biopsy: enrichment and determination of circulating biomarkers","volume":"2","author":"Zhu","year":"2023","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.phrs.2024.107302_bib125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.32604\/or.2022.027281","article-title":"Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells","volume":"31","author":"Stickler","year":"2023","journal-title":"Oncol. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1158\/2159-8290.CD-15-1283","article-title":"Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer","volume":"6","author":"Russo","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phrs.2024.107302_bib127","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","article-title":"APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity","volume":"5","author":"Swanton","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phrs.2024.107302_bib128","first-page":"108","article-title":"Emerging nano-\/biotechnology drives oncolytic virus-activated and combined cancer immunotherapy","volume":"6","author":"Fang","year":"2023","journal-title":"Res. (Wash. D. C. )"},{"key":"10.1016\/j.phrs.2024.107302_bib129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40824-023-00369-8","article-title":"Emerging biomaterials for tumor immunotherapy","volume":"27","author":"Xiao","year":"2023","journal-title":"Biomater. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.21147\/j.issn.1000-9604.2023.02.03","article-title":"Transforming cancer cells for long-term living with cancer: an inspiring new approach","volume":"35","author":"Jiang","year":"2023","journal-title":"Chin. J. Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib131","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107302_bib132","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","article-title":"Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial","volume":"22","author":"Powles","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2024.107302_bib133","first-page":"11536","article-title":"Advanced\/metastatic bladder cancer: current status and future directions","volume":"24","author":"Facchini","year":"2020","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.phrs.2024.107302_bib134","doi-asserted-by":"crossref","first-page":"597","DOI":"10.32604\/or.2024.045442","article-title":"Clinical implications of single cell sequencing for bladder cancer","volume":"32","author":"Yadollahvandmiandoab","year":"2024","journal-title":"Oncol. Res"},{"key":"10.1016\/j.phrs.2024.107302_bib135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.21147\/j.issn.1000-9604.2024.02.05","article-title":"New roles of tumor-derived exosomes in tumor microenvironment","volume":"36","author":"Chen","year":"2024","journal-title":"Chin. J. Cancer Res"},{"key":"10.1016\/j.phrs.2024.107302_bib136","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1158\/2326-6066.CIR-18-0758","article-title":"The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes","volume":"7","author":"Pfannstiel","year":"2019","journal-title":"Cancer Immunol. Res"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824002470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824002470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T02:22:11Z","timestamp":1724466131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824002470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":136,"alternative-id":["S1043661824002470"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107302","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107302"}}